Aardvark Therapeutics(AARD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AARD Aardvark Therapeutics

提前休市 12-24 13:00:00 EST

14.26

+0.11

+0.78%

盘后14.26

+0.000.00%

14:23 EST

最高14.61	最低14.00	成交量6.37万
今开14.15	昨收14.15	日振幅4.31%
总市值3.09亿	流通市值8,396万	总股本2,170万
成交额90.63万	换手率1.08%	流通股本588.80万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AARD","market":"US","secType":"STK","nameCN":"Aardvark Therapeutics","latestPrice":14.26,"timestamp":1766599200000,"preClose":14.15,"halted":0,"volume":63747,"hourTrading":{"tag":"盘后","latestPrice":14.26,"preClose":14.26,"latestTime":"14:23 EST","volume":6350,"amount":90519.89135,"timestamp":1766604214554},"delay":0,"floatShares":5888000,"shares":21696893,"eps":-0.648,"marketStatus":"提前休市","change":0.11,"latestTime":"12-24 13:00:00 EST","open":14.15,"high":14.6092,"low":14,"amount":906335.785647,"amplitude":0.043053,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.648,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766739600000},"marketStatusCode":6,"adr":0,"listingDate":1739509200000,"exchange":"NASDAQ","adjPreClose":14.15,"preHourTrading":{"tag":"盘前","latestPrice":14.37,"preClose":14.15,"latestTime":"08:33 EST","volume":10,"amount":143.7,"timestamp":1766583205378},"postHourTrading":{"tag":"盘后","latestPrice":14.26,"preClose":14.26,"latestTime":"14:23 EST","volume":6350,"amount":90519.89135,"timestamp":1766604214554},"volumeRatio":0.303843},"requestUrl":"/m/hq/s/AARD","defaultTab":"news","newsList":[{"id":"1119474932","title":"Aardvark Therapeutics Inc - 加拿大和英国的临床试验地点已获得注册许可","url":"https://stock-news.laohu8.com/highlight/detail?id=1119474932","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119474932?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:24","pubTimestamp":1765401846,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics Inc - 加拿大和英国的临床试验地点已获得注册许可","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"1150804035","title":"Aardvark Therapeutics在澳大利亚进行的英雄三期试验中宣布首位患者接受治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1150804035","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150804035?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:05","pubTimestamp":1765400713,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics在澳大利亚进行的英雄三期试验中宣布首位患者接受治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"1194886481","title":"Aardvark Therapeutics宣布FDA就扩大针对普拉德-威利综合征的三期Hero试验人群的协议修订达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1194886481","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194886481?lang=zh_cn&edition=full","pubTime":"2025-10-08 20:02","pubTimestamp":1759924977,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics宣布FDA就扩大针对普拉德-威利综合征的三期Hero试验人群的协议修订达成一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"gpt_icon":0},{"id":"2518226139","title":"Aardvark Therapeutics(AARD.US)获B of A Securities首次覆盖，给予买入评级, 目标价22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226139","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518226139?lang=zh_cn&edition=full","pubTime":"2025-03-10 20:41","pubTimestamp":1741610495,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics(AARD.US)获B of A Securities首次覆盖，给予买入评级, 目标价22.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/10204148634837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","AARD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://aardvarktherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.5101},{"period":"3month","weight":0.1627},{"period":"6month","weight":0.0209},{"period":"1year","weight":-0.1156},{"period":"ytd","weight":-0.1156}],"compareEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0439},{"period":"3month","weight":0.0406},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.1568},{"period":"ytd","weight":0.1738}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aardvark Therapeutics, Inc.于2017年5月17日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于开发新颖的小分子疗法，以激活用于治疗代谢疾病的先天稳态途径。该公司瞄准了与缓解饥饿相关的生物途径，该公司认为这些途径有可能为患者带来变革性的结果。该公司已将精力集中在开发选择性化合物上，针对与饥饿相关的情况开发苦味受体。","exchange":"NASDAQ","name":"Aardvark Therapeutics","nameEN":"Aardvark Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aardvark Therapeutics(AARD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aardvark Therapeutics(AARD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aardvark Therapeutics,AARD,Aardvark Therapeutics股票,Aardvark Therapeutics股票老虎,Aardvark Therapeutics股票老虎国际,Aardvark Therapeutics行情,Aardvark Therapeutics股票行情,Aardvark Therapeutics股价,Aardvark Therapeutics股市,Aardvark Therapeutics股票价格,Aardvark Therapeutics股票交易,Aardvark Therapeutics股票购买,Aardvark Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aardvark Therapeutics(AARD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aardvark Therapeutics(AARD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}